What exactly is driving the reduction remains unknown at this time, though research released Jan. 18 links vaccinations even after the onset of a COVID-19 infection to lower post-COVID-19 risk factors.
However, KFF points to other studies showing that “evidence is mixed as to whether vaccines reduce the likelihood of getting long COVID, or if they reduce the severity of long COVID among people who already have it.”
Work to investigate the long-term effects of infection continues as part of a national effort launched in August 2022 by the Department of Health and Human Services. The agency released a National Research Action Plan on long COVID-19, which details that its plan “builds on ongoing research supported or conducted by the U.S. government and aims to accelerate and expand it, in addition to calling for enhanced action by the private sector,” and “a comprehensive, multidisciplinary” approach.
Several other details have also emerged regarding the effects of long COVID-19 in just the first month of 2023.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
